BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 15858113)

  • 1. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nevus and malignant cutaneous melanoma].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
    Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocytic naevi, melanoma and sun exposure.
    Augustsson A
    Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of melanocytic skin lesions in Egypt.
    Hussein MR; Elsers DA; Fadel SA; Omar AE
    Eur J Cancer Prev; 2006 Feb; 15(1):64-8. PubMed ID: 16374232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital melanocytic naevi and cutaneous melanoma.
    Berg P; Lindelöf B
    Melanoma Res; 2003 Oct; 13(5):441-5. PubMed ID: 14512785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
    Hussein MR; Elsers DA; Fadel SA; Omar AE
    J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic naevi and melanoma: an epidemiological perspective.
    Swerdlow AJ; Green A
    Br J Dermatol; 1987 Aug; 117(2):137-46. PubMed ID: 3307891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulators of malignant melanoma of the skin.
    Cerroni L; Kerl H
    Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
    Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
    Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new concept of melanocytic neoplasia pathogenesis based on the phenotype of common acquired nevi.
    Batistatou A; Zioga A; Panelos J; Massi D; Agnantis NJ; Charalabopoulos K
    Med Hypotheses; 2007; 69(6):1334-9. PubMed ID: 17459602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
    Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
    Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin of cutaneous melanoma in a congenital dysplastic nevus spilus.
    Rhodes AR; Mihm MC
    Arch Dermatol; 1990 Apr; 126(4):500-5. PubMed ID: 2321995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index.
    Berman DM; Wincovitch S; Garfield S; Romeo MJ
    J Clin Pathol; 2005 Nov; 58(11):1206-10. PubMed ID: 16254113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.